PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11311056-5	2001	Daunorubicin and doxorubicin, two widely used antineoplastic agents in tumor therapy, were covalently linked to NPY via two spacers that differ in stability: an acid-sensitive hydrazone bond at the 13-keto position of daunorubicin and a stable amide bond at the 3"-amino position of daunorubicin and doxorubicin.	Daunorubicin	0-12	neuropeptide Y	Homo sapiens	112-115	
11311056-5	2001	Daunorubicin and doxorubicin, two widely used antineoplastic agents in tumor therapy, were covalently linked to NPY via two spacers that differ in stability: an acid-sensitive hydrazone bond at the 13-keto position of daunorubicin and a stable amide bond at the 3"-amino position of daunorubicin and doxorubicin.	Daunorubicin	218-230	neuropeptide Y	Homo sapiens	112-115	
11311056-5	2001	Daunorubicin and doxorubicin, two widely used antineoplastic agents in tumor therapy, were covalently linked to NPY via two spacers that differ in stability: an acid-sensitive hydrazone bond at the 13-keto position of daunorubicin and a stable amide bond at the 3"-amino position of daunorubicin and doxorubicin.	Daunorubicin	283-295	neuropeptide Y	Homo sapiens	112-115	
11311056-10	2001	We found evidence that the active conjugate [C(15)]-NPY-Dauno-HYD releases daunorubicin, which is localized close to the nucleus, whereas the inactive conjugate [C(15)]-NPY-Dauno-MBS is distributed distantly from the nucleus and does not seem to release the drug within the cell.	Daunorubicin	75-87	neuropeptide Y	Homo sapiens	52-55